Copyright Reports & Markets. All rights reserved.

Global Non-invasive DNA Prenatal Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Non-invasive DNA Prenatal Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Non-invasive DNA Prenatal Testing by Type
    • 1.3.1 Overview: Global Non-invasive DNA Prenatal Testing Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type in 2022
    • 1.3.3 Equipment
    • 1.3.4 Consumables
  • 1.4 Global Non-invasive DNA Prenatal Testing Market by Application
    • 1.4.1 Overview: Global Non-invasive DNA Prenatal Testing Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Non-invasive DNA Prenatal Testing Market Size & Forecast
  • 1.6 Global Non-invasive DNA Prenatal Testing Market Size and Forecast by Region
    • 1.6.1 Global Non-invasive DNA Prenatal Testing Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Non-invasive DNA Prenatal Testing Market Size by Region, (2018-2029)
    • 1.6.3 North America Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
    • 1.6.6 South America Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Illumina
    • 2.1.1 Illumina Details
    • 2.1.2 Illumina Major Business
    • 2.1.3 Illumina Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.1.4 Illumina Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Illumina Recent Developments and Future Plans
  • 2.2 Roche
    • 2.2.1 Roche Details
    • 2.2.2 Roche Major Business
    • 2.2.3 Roche Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.2.4 Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Roche Recent Developments and Future Plans
  • 2.3 Natera
    • 2.3.1 Natera Details
    • 2.3.2 Natera Major Business
    • 2.3.3 Natera Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.3.4 Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Natera Recent Developments and Future Plans
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.4.4 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.5 F. Hoffman-La Roche
    • 2.5.1 F. Hoffman-La Roche Details
    • 2.5.2 F. Hoffman-La Roche Major Business
    • 2.5.3 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.5.4 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 F. Hoffman-La Roche Recent Developments and Future Plans
  • 2.6 Pacific Biosciences Of California
    • 2.6.1 Pacific Biosciences Of California Details
    • 2.6.2 Pacific Biosciences Of California Major Business
    • 2.6.3 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.6.4 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Pacific Biosciences Of California Recent Developments and Future Plans
  • 2.7 Perkinelmer
    • 2.7.1 Perkinelmer Details
    • 2.7.2 Perkinelmer Major Business
    • 2.7.3 Perkinelmer Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.7.4 Perkinelmer Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Perkinelmer Recent Developments and Future Plans
  • 2.8 LifeCodexx
    • 2.8.1 LifeCodexx Details
    • 2.8.2 LifeCodexx Major Business
    • 2.8.3 LifeCodexx Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.8.4 LifeCodexx Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 LifeCodexx Recent Developments and Future Plans
  • 2.9 Agilent Technologies
    • 2.9.1 Agilent Technologies Details
    • 2.9.2 Agilent Technologies Major Business
    • 2.9.3 Agilent Technologies Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.9.4 Agilent Technologies Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Agilent Technologies Recent Developments and Future Plans
  • 2.10 Labcorp
    • 2.10.1 Labcorp Details
    • 2.10.2 Labcorp Major Business
    • 2.10.3 Labcorp Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.10.4 Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Labcorp Recent Developments and Future Plans
  • 2.11 Mutiplicon
    • 2.11.1 Mutiplicon Details
    • 2.11.2 Mutiplicon Major Business
    • 2.11.3 Mutiplicon Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.11.4 Mutiplicon Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Mutiplicon Recent Developments and Future Plans
  • 2.12 Premaitha Health
    • 2.12.1 Premaitha Health Details
    • 2.12.2 Premaitha Health Major Business
    • 2.12.3 Premaitha Health Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.12.4 Premaitha Health Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Premaitha Health Recent Developments and Future Plans
  • 2.13 Beijing BGI
    • 2.13.1 Beijing BGI Details
    • 2.13.2 Beijing BGI Major Business
    • 2.13.3 Beijing BGI Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.13.4 Beijing BGI Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Beijing BGI Recent Developments and Future Plans
  • 2.14 Berry Genomics
    • 2.14.1 Berry Genomics Details
    • 2.14.2 Berry Genomics Major Business
    • 2.14.3 Berry Genomics Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.14.4 Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Berry Genomics Recent Developments and Future Plans
  • 2.15 Darui Biological
    • 2.15.1 Darui Biological Details
    • 2.15.2 Darui Biological Major Business
    • 2.15.3 Darui Biological Non-invasive DNA Prenatal Testing Product and Solutions
    • 2.15.4 Darui Biological Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Darui Biological Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Non-invasive DNA Prenatal Testing Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Non-invasive DNA Prenatal Testing by Company Revenue
    • 3.2.2 Top 3 Non-invasive DNA Prenatal Testing Players Market Share in 2022
    • 3.2.3 Top 6 Non-invasive DNA Prenatal Testing Players Market Share in 2022
  • 3.3 Non-invasive DNA Prenatal Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Non-invasive DNA Prenatal Testing Market: Region Footprint
    • 3.3.2 Non-invasive DNA Prenatal Testing Market: Company Product Type Footprint
    • 3.3.3 Non-invasive DNA Prenatal Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Non-invasive DNA Prenatal Testing Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Non-invasive DNA Prenatal Testing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Non-invasive DNA Prenatal Testing Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
  • 6.2 North America Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
  • 6.3 North America Non-invasive DNA Prenatal Testing Market Size by Country
    • 6.3.1 North America Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
    • 6.3.2 United States Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
  • 7.2 Europe Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
  • 7.3 Europe Non-invasive DNA Prenatal Testing Market Size by Country
    • 7.3.1 Europe Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 7.3.3 France Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region
    • 8.3.1 Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Region (2018-2029)
    • 8.3.2 China Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 8.3.5 India Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
  • 9.2 South America Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
  • 9.3 South America Non-invasive DNA Prenatal Testing Market Size by Country
    • 9.3.1 South America Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country
    • 10.3.1 Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Non-invasive DNA Prenatal Testing Market Drivers
  • 11.2 Non-invasive DNA Prenatal Testing Market Restraints
  • 11.3 Non-invasive DNA Prenatal Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Non-invasive DNA Prenatal Testing Industry Chain
  • 12.2 Non-invasive DNA Prenatal Testing Upstream Analysis
  • 12.3 Non-invasive DNA Prenatal Testing Midstream Analysis
  • 12.4 Non-invasive DNA Prenatal Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Non-invasive DNA Prenatal Testing market size was valued at USD 4839.2 million in 2022 and is forecast to a readjusted size of USD 10360 million by 2029 with a CAGR of 11.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Non-invasive prenatal DNA testing is a new generation of prenatal testing technology that uses next-generation high-throughput sequencing to detect fetal chromosomal abnormalities.
    This report is a detailed and comprehensive analysis for global Non-invasive DNA Prenatal Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Non-invasive DNA Prenatal Testing market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Non-invasive DNA Prenatal Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Non-invasive DNA Prenatal Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Non-invasive DNA Prenatal Testing market shares of main players, in revenue ($ Million), 2018-2023.
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Non-invasive DNA Prenatal Testing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace.
    This report profiles key players in the global Non-invasive DNA Prenatal Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Roche, Natera, Thermo Fisher Scientific and F. Hoffman-La Roche, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Non-invasive DNA Prenatal Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Equipment
    Consumables
    Market segment by Application
    Hospital
    Clinic
    Other
    Market segment by players, this report covers
    Illumina
    Roche
    Natera
    Thermo Fisher Scientific
    F. Hoffman-La Roche
    Pacific Biosciences Of California
    Perkinelmer
    LifeCodexx
    Agilent Technologies
    Labcorp
    Mutiplicon
    Premaitha Health
    Beijing BGI
    Berry Genomics
    Darui Biological
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Non-invasive DNA Prenatal Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Non-invasive DNA Prenatal Testing, with revenue, gross margin and global market share of Non-invasive DNA Prenatal Testing from 2018 to 2023.
    Chapter 3, the Non-invasive DNA Prenatal Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-invasive DNA Prenatal Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Non-invasive DNA Prenatal Testing.
    Chapter 13, to describe Non-invasive DNA Prenatal Testing research findings and conclusion.

    Buy now